J&J tells jury it properly warned about Levaquin risks; Pfizer wins Viagra trademark fight;

@FiercePharma: $BMY earnings might have disappointed analysts--and Plavix is faltering--but newer meds grew--Bloomberg. Article | Follow @FiercePharma

> Johnson & Johnson ($JNJ) lawyers told Minneapolis jurors it properly warned about the risks of its antibiotic drug Levaquin, and so shouldn't be held liable for a patient's tendon injuries. Article

> Pfizer ($PFE) won a court battle over the Viagra trademark, preventing an energy drinks company from using the name Viaguara. Story

> Roche ($RHHBY) said it hasn't settled any claims that its Raptiva psoriasis drug triggered lethal infections, and a plaintiffs' lawyer who had announced a deal called his statement "wishful thinking." More

> Pfizer's ($PFE) aggressive bid to keep Lipitor sales might be protecting revenues at the expense of profits, said Paul Bisaro, CEO at Pfizer's authorized-generic partner Watson Pharmaceuticals ($WPI). Report

> The European Commission broadened use of the Merck Serono multiple sclerosis drug Rebif to patients with early signs of the disease. News

> Playing down misuse-of-funds allegations at the Global Fund to Fight AIDS, Bill Gates gave another $750 million to the organization and called on governments to pitch in more as well. Story

> Spectrum Pharmaceuticals ($SPPI) agreed to pay Bayer ($BAY) almost $25 million for the rights to market a lymphoma drug, Zevalin, outside the U.S. More

> European regulators are considering requiring API manufacturers to verify the sources of their raw materials as part of revised good manufacturing practice rules. Report

> Drug wholesaler AmerisourceBergen ($ABC) posted a slight rise in fourth-quarter profits to $162.1 million, falling short of analyst estimates. Article

> Grief could be characterized as a form of depression in the new Diagnostic and Statistical Manual of Mental Disorders. News

> A drug used in the U.S. to promote growth in pigs, but banned in the E.U. and other countries, has limited pork exports to key markets. Report

Biotech News

@FierceBiotech: A future threat to Provenge? Researchers target multiple tumors (prostate, lung, others) in new cancer vaccine study. Article | Follow @FierceBiotech

@JohnCFierce: Interesting note: Abingworth, a major Avila investor, also cashed out of Intellikine ($310M) in Dec. For VCs, M&A is key this year. | Follow @JohnCFierce

@MarkHFierce: Obama is pushing (again) for more funding for basic research. Is anybody going to listen this time? More | Follow @MarkHFierce

> Celgene snaps up Avila Therapeutics in $925M buyout. News

> Amgen scoops up Micromet tumor-fighting pipeline for $1.2B. Report

Vaccines News

> Common chemicals threaten childhood vaccines. Story

> Researchers target multiple tumors in new cancer vaccine study. More

> Nanoparticles hijack immune response. Article

> Late-stage Galena vax offers hope for breast cancer patients. Story

Pharma Manufacturing News

> Owner arrested in Pakistani drug deaths cites Big Pharma conspiracy. Article

> Abbott includes manufacturing in 700 job cuts. News

> Warnings analysis spotlights analytics weakness. Story

> Merck 'program of projects' earns facility award. More

And Finally... A Wisconsin scientist said his team's souped-up version of bird flu wasn't as lethal as the Dutch team's. Report

Suggested Articles

Moderna, racing ahead with COVID-19 vaccine R&D, completed enrollment for its late-stage trial—and moved one step closer to approval.

The only thing certain about 2020 has been uncertainty, leaving almost everyone wondering what might come next.

Since the FDA released new COVID-19 vaccine guidance, HHS Secretary Alex Azar has discussed firing FDA Commissioner Stephen Hahn, Politico reports.